Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  The Yield Growth Corp.    BOSS   CA98584W2067

THE YIELD GROWTH CORP.

(BOSS)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

YIELD GROWTH : Reports Voting Results of its 2020 Annual General Meeting

share with twitter share with LinkedIn share with facebook
06/29/2020 | 10:45am EDT

The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (Frankfurt:YG3) is pleased to report the results of its Annual General Meeting (the 'Meeting'), held on Thursday, June 25, 2020 at 200 1238 Homer Street, Vancouver, BC.

A total of 18,877,921 or 14.51% of the Company's issued and outstanding shares were represented at the Meeting, and each resolution was approved by over 99% of the shares voted.

At the Meeting, shareholders approved the appointment of Saturna Group Chartered Professional Accountants LLP as the auditors of the Company for the upcoming year, and the re election of Penny White, Spiros Margaris and Yucai (Rick) Huang to the Company's board of directors.

About The Yield Growth Corp.

The Yield Growth Corp. (CSE: BOSS),(OTCQB: BOSQF) is a phytoceutical and consumer packaged goods company that develops and acquires intellectual property and other assets related to plant based products and therapeutics, and develops, manufactures, markets, sells and distributes plant based productsthat improve lives. It has over 200 proprietary wellnessformulas at various stages of commercialization, including over 20 products that are now for sale through ecommerce or brick and mortar retail stores. It is currently launching several hand sanitizer productsin response to COVID19. It has 14 patent applicationsfiled in what the Global Wellness Institute reports is a $4.2 trillion dollar global wellness market. Its majority owned subsidiary NeonMind BiosciencesInc. is launching a line of medicinal mushroom products and is developing intellectual property in the emerging area of psychedelic medicine. The Yield Growth management team has deep experience with global brandsincluding Johnson & Johnson, Procter & Gamble, Skechers and Aritzia.

Contact:

Email: invest@yieldgrowth.com

(C) 2020 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
Latest news on THE YIELD GROWTH CORP.
07/02Three Ex-U.S. and Canada Cannabis Stocks to Consider for Your Portfolio -- CF..
NE
07/02This May be the Trick to Treating a Massive $16 Billion Weight Issue
NE
06/29YIELD GROWTH : Reports Voting Results of its 2020 Annual General Meeting
AQ
06/25Yield Growth Receives Health Canada Notification Numbers for 23 Plant-Based P..
NE
06/24Yield Growth Announces Financing
NE
06/24The Future of Mental Health Will be Led by Psychedelics
NE
06/23Yield Growth Announces New Canadian Distributor for its Urban Juve Products
NE
06/19These Psychedelic Drugs May Be Key to Revolutionizing Weight Loss Treatment
NE
06/18NeonMind Files Patent Application for Therapeutic Use of DMT
NE
06/17Much Like Cannabis, Support for Psilocybin Legalization is Gaining Support in..
NE
More news
Financials
Sales 2019 4,02 M 2,96 M 2,96 M
Net income 2019 -16,0 M -11,8 M -11,8 M
Net cash 2019 0,54 M 0,40 M 0,40 M
P/E ratio 2019 -1,43x
Yield 2019 -
Capitalization 14,3 M 10,5 M 10,5 M
EV / Sales 2018 -
EV / Sales 2019 6,43x
Nbr of Employees 19
Free-Float 67,2%
Chart THE YIELD GROWTH CORP.
Duration : Period :
The Yield Growth Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE YIELD GROWTH CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 0,45 CAD
Last Close Price 0,10 CAD
Spread / Highest target 350%
Spread / Average Target 350%
Spread / Lowest Target 350%
EPS Revisions
Managers
NameTitle
Penny White President, Chief Executive Officer & Director
Tamara Melck Chief Operating Officer
Yu Cai Huang Chief Financial Officer
Spiros Margaris Independent Director
Amy Frankel Secretary, VP-People & General Counsel
Sector and Competitors
1st jan.Capitalization (M$)
THE YIELD GROWTH CORP.-47.37%11
JOHNSON & JOHNSON-3.36%371 399
ROCHE HOLDING AG4.71%295 898
MERCK & CO., INC.-13.38%198 849
NOVARTIS AG-10.36%192 057
PFIZER, INC.-11.92%191 697